Eps Summary of Perrigo Company plc

Perrigo Company plc's latest annual eps in 2023 was -0.09 USD , up 90.32% from previous year.
Perrigo Company plc's latest quarterly eps in 2024 Q1 was 0.03 USD , up 112.5% from previous quarter.
Perrigo Company plc reported an annual eps of -0.97 USD in 2022, up 1.02% from previous year.
Perrigo Company plc reported an annual eps of -0.98 USD in 2021, up 17.65% from previous year.
Perrigo Company plc reported a quarterly eps of -0.77 USD for 2024 Q2, down -2666.67% from previous quarter.
Perrigo Company plc reported a quarterly eps of -0.24 USD for 2023 Q4, down -318.18% from previous quarter.

Annual Eps Chart of Perrigo Company plc (2023 - 1992)

Historical Annual Eps of Perrigo Company plc (2023 - 1992)

Year	Eps	Eps Growth
2023	-0.09 USD	90.32%
2022	-0.97 USD	1.02%
2021	-0.98 USD	17.65%
2020	-1.19 USD	-211.21%
2019	1.07 USD	12.63%
2018	0.95 USD	13.1%
2017	0.84 USD	103.0%
2016	-28.01 USD	-3144.57%
2015	0.92 USD	-48.31%
2014	1.78 USD	-62.21%
2013	4.71 USD	9.28%
2012	4.31 USD	17.44%
2011	3.67 USD	51.03%
2010	2.43 USD	55.77%
2009	1.56 USD	6.85%
2008	1.46 USD	82.5%
2007	0.80 USD	3.9%
2006	0.77 USD	116.85%
2005	-4.57 USD	-497.39%
2004	1.15 USD	49.35%
2003	0.77 USD	11.59%
2002	0.69 USD	81.58%
2001	0.38 USD	46.15%
2000	0.26 USD	1200.0%
1999	0.02 USD	102.9%
1998	-0.69 USD	-218.97%
1997	0.58 USD	11.54%
1996	0.52 USD	-10.34%
1995	0.58 USD	-18.31%
1994	0.71 USD	22.41%
1993	0.58 USD	41.46%
1992	0.41 USD	0.0%

Year	Eps	Eps Growth
2024 Q1	0.03 USD	112.5%
2024 Q2	-0.77 USD	-2666.67%
2023 Q4	-0.24 USD	-318.18%
2023 Q2	0.07 USD	902.44%
2023 Q1	-0.01 USD	91.3%
2023 FY	- USD	90.32%
2023 Q3	0.11 USD	67.17%
2022 Q1	-0.01 USD	-104.17%
2022 FY	- USD	1.02%
2022 Q3	-0.39 USD	18.75%
2022 Q4	-0.09 USD	75.82%
2022 Q2	-0.48 USD	-4700.0%
2021 Q3	-0.44 USD	-2.33%
2021 FY	- USD	17.65%
2021 Q1	0.29 USD	122.48%
2021 Q2	-0.43 USD	-248.28%
2021 Q4	0.24 USD	154.55%
2020 Q1	0.78 USD	657.14%
2020 Q4	-1.29 USD	-14.16%
2020 Q3	-1.13 USD	-356.82%
2020 FY	- USD	-211.21%
2020 Q2	0.44 USD	-43.59%
2019 FY	- USD	12.63%
2019 Q3	0.68 USD	871.43%
2019 Q4	-0.14 USD	-120.59%
2019 Q1	0.47 USD	-21.67%
2019 Q2	0.07 USD	-85.11%
2018 Q4	0.60 USD	222.45%
2018 FY	- USD	13.1%
2018 Q2	0.26 USD	-54.39%
2018 Q1	0.57 USD	9.62%
2018 Q3	-0.49 USD	-288.46%
2017 Q1	0.50 USD	102.74%
2017 Q2	-0.49 USD	-198.0%
2017 Q3	0.31 USD	163.27%
2017 Q4	0.52 USD	67.74%
2017 FY	- USD	103.0%
2016 Q4	-18.27 USD	-108.56%
2016 FY	- USD	-3144.57%
2016 Q2	-3.73 USD	-301.08%
2016 Q1	-0.93 USD	-25.68%
2016 Q3	-8.76 USD	-134.85%
2015 Q1	-0.68 USD	-230.77%
2015 Q4	-0.74 USD	-196.1%
2015 FY	- USD	-48.31%
2015 Q2	0.39 USD	157.35%
2015 Q3	0.77 USD	97.44%
2014 Q3	0.72 USD	-26.53%
2014 FY	- USD	-62.21%
2014 Q1	0.36 USD	141.38%
2014 Q2	0.98 USD	172.22%
2014 Q4	0.52 USD	-27.78%
2013 Q3	1.18 USD	-6.35%
2013 Q4	-0.87 USD	-173.73%
2013 Q1	1.19 USD	5.31%
2013 FY	- USD	9.28%
2013 Q2	1.26 USD	5.88%
2012 FY	- USD	17.44%
2012 Q3	1.13 USD	-8.87%
2012 Q2	1.24 USD	0.0%
2012 Q1	1.24 USD	15.89%
2012 Q4	1.13 USD	0.0%
2011 Q1	0.96 USD	-2.04%
2011 FY	- USD	51.03%
2011 Q4	1.07 USD	40.79%
2011 Q3	0.76 USD	-18.28%
2011 Q2	0.93 USD	-3.12%
2010 Q3	0.81 USD	50.0%
2010 Q4	0.98 USD	20.99%
2010 Q1	0.68 USD	3.03%
2010 Q2	0.54 USD	-20.59%
2010 FY	- USD	55.77%
2009 Q1	0.50 USD	85.19%
2009 Q3	0.56 USD	47.37%
2009 Q4	0.66 USD	17.86%
2009 FY	- USD	6.85%
2009 Q2	0.38 USD	-24.0%
2008 Q4	0.27 USD	-34.15%
2008 Q1	0.43 USD	16.22%
2008 Q2	0.30 USD	-30.23%
2008 Q3	0.41 USD	36.67%
2008 FY	- USD	82.5%
2007 Q4	0.37 USD	0.0%
2007 FY	- USD	3.9%
2007 Q1	0.19 USD	-17.39%
2007 Q3	0.37 USD	85.0%
2007 Q2	0.20 USD	5.26%
2006 FY	- USD	116.85%
2006 Q4	0.23 USD	27.78%
2006 Q3	0.18 USD	38.46%
2006 Q2	0.13 USD	-43.48%
2006 Q1	0.23 USD	-14.81%
2005 Q2	-0.09 USD	98.17%
2005 FY	- USD	-497.39%
2005 Q4	0.27 USD	92.86%
2005 Q3	0.14 USD	248.15%
2005 Q1	-5.15 USD	-2440.91%
2004 Q2	0.12 USD	-52.0%
2004 Q1	0.25 USD	-54.55%
2004 FY	- USD	49.35%
2004 Q4	0.22 USD	-12.0%
2004 Q3	0.25 USD	108.33%
2003 Q1	0.20 USD	-16.67%
2003 Q4	0.55 USD	129.17%
2003 Q2	0.06 USD	-68.8%
2003 Q3	0.24 USD	284.62%
2003 FY	- USD	11.59%
2002 Q3	0.28 USD	1518.5%
2002 Q1	0.25 USD	19.05%
2002 FY	- USD	81.58%
2002 Q4	0.24 USD	-14.29%
2002 Q2	0.02 USD	-93.08%
2001 Q4	0.21 USD	16.67%
2001 Q1	0.14 USD	1300.0%
2001 FY	- USD	46.15%
2001 Q2	0.09 USD	-38.64%
2001 Q3	0.18 USD	109.55%
2000 Q1	0.09 USD	-40.0%
2000 FY	- USD	1200.0%
2000 Q3	0.14 USD	227.27%
2000 Q2	-0.11 USD	-222.22%
2000 Q4	0.01 USD	-92.86%
1999 Q3	0.14 USD	448.26%
1999 FY	- USD	102.9%
1999 Q1	0.13 USD	30.0%
1999 Q2	-0.04 USD	-130.92%
1999 Q4	0.15 USD	7.14%
1998 Q4	0.10 USD	158.82%
1998 FY	- USD	-218.97%
1998 Q2	-1.21 USD	-1030.77%
1998 Q1	0.13 USD	-31.58%
1998 Q3	-0.17 USD	85.95%
1997 FY	- USD	11.54%
1997 Q3	0.14 USD	16.67%
1997 Q2	0.12 USD	-20.0%
1997 Q1	0.15 USD	-16.67%
1997 Q4	0.19 USD	35.71%
1996 Q3	0.14 USD	120.82%
1996 Q2	0.06 USD	-54.71%
1996 Q1	0.14 USD	-12.5%
1996 FY	- USD	-10.34%
1996 Q4	0.18 USD	28.57%
1995 FY	- USD	-18.31%
1995 Q3	0.16 USD	125.04%
1995 Q2	0.07 USD	-52.6%
1995 Q4	0.16 USD	0.0%
1995 Q1	0.15 USD	-11.76%
1994 Q4	0.17 USD	-10.53%
1994 FY	- USD	22.41%
1994 Q3	0.19 USD	26.67%
1994 Q1	0.17 USD	-15.0%
1994 Q2	0.15 USD	-11.76%
1993 FY	- USD	41.46%
1993 Q1	0.15 USD	0.0%
1993 Q2	0.15 USD	0.0%
1993 Q3	0.19 USD	26.67%
1993 Q4	0.20 USD	5.26%
1992 Q4	0.15 USD	7.14%
1992 Q1	0.11 USD	0.0%
1992 Q2	0.10 USD	-9.09%
1992 Q3	0.14 USD	40.0%
1992 FY	- USD	0.0%
1991 Q4	0.11 USD	10.0%
1991 Q3	0.10 USD	0.0%

Peer Eps Comparison of Perrigo Company plc

Name	Eps	Eps Difference
Thermo Fisher Scientific Inc.	15.53 USD	100.605%
Agios Pharmaceuticals, Inc.	-6.33 USD	98.517%
Atara Biotherapeutics, Inc.	-65.18 USD	99.856%
Cara Therapeutics, Inc.	-2.19 USD	95.712%
uniQure N.V.	-6.47 USD	98.549%
Amicus Therapeutics, Inc.	-0.51 USD	81.588%
bluebird bio, Inc.	-1.93 USD	95.135%
Imunon, Inc.	-2.16 USD	95.653%
Dynavax Technologies Corporation	-0.05 USD	-89.315%
Editas Medicine, Inc.	-2.02 USD	95.351%
Illumina, Inc.	-7.35 USD	98.722%
Iovance Biotherapeutics, Inc.	-1.89 USD	95.032%
IQVIA Holdings Inc.	7.39 USD	101.271%
Mettler-Toledo International Inc.	36.10 USD	100.26%
Myriad Genetics, Inc.	-1.39 USD	93.245%
Neurocrine Biosciences, Inc.	2.56 USD	103.668%
Sarepta Therapeutics, Inc.	-5.80 USD	98.381%
Supernus Pharmaceuticals, Inc.	0.02 USD	489.627%
Verastem, Inc.	-3.96 USD	97.629%
Walgreens Boots Alliance, Inc.	-10.01 USD	99.062%
Waters Corporation	10.87 USD	100.864%
Biogen Inc.	8.02 USD	101.171%
Nektar Therapeutics	-1.45 USD	93.524%
Corbus Pharmaceuticals Holdings, Inc.	-10.31 USD	99.089%
Heron Therapeutics, Inc.	-0.80 USD	88.263%
Unity Biotechnology, Inc.	-2.70 USD	96.522%
BioMarin Pharmaceutical Inc.	0.89 USD	110.551%
Sangamo Therapeutics, Inc.	-1.48 USD	93.655%
Evolus, Inc.	-1.08 USD	91.306%
Adicet Bio, Inc.	-3.31 USD	97.163%
Aclaris Therapeutics, Inc.	-1.27 USD	92.606%
Regeneron Pharmaceuticals, Inc.	37.05 USD	100.253%
Esperion Therapeutics, Inc.	-2.03 USD	95.374%
FibroGen, Inc.	-2.92 USD	96.784%
Agilent Technologies, Inc.	4.22 USD	102.225%
OPKO Health, Inc.	-0.25 USD	62.44%
Homology Medicines, Inc.	-7.41 USD	98.733%
Geron Corporation	-0.32 USD	70.656%
Alnylam Pharmaceuticals, Inc.	-3.52 USD	97.332%
Exelixis, Inc.	0.65 USD	114.446%
Viking Therapeutics, Inc.	-0.91 USD	89.681%
Anavex Life Sciences Corp.	-0.60 USD	84.35%
Intellia Therapeutics, Inc.	-5.42 USD	98.268%
Zoetis Inc.	5.08 USD	101.848%
Axsome Therapeutics, Inc.	-5.27 USD	98.218%
Abeona Therapeutics Inc.	-2.53 USD	96.289%
Vertex Pharmaceuticals Incorporated	14.05 USD	100.668%
Kala Pharmaceuticals, Inc.	-17.35 USD	99.459%
Ionis Pharmaceuticals, Inc.	-2.56 USD	96.332%
Corcept Therapeutics Incorporated	1.02 USD	109.206%
Halozyme Therapeutics, Inc.	2.13 USD	104.408%
Blueprint Medicines Corporation	-8.37 USD	98.878%
Insmed Incorporated	-5.34 USD	98.242%
TG Therapeutics, Inc.	0.09 USD	205.151%
Incyte Corporation	2.67 USD	103.517%
Emergent BioSolutions Inc.	-14.85 USD	99.368%

Global Stocks Search

Perrigo Company plc (0Y5E.L)

Eps Summary of Perrigo Company plc

Annual Eps Chart of Perrigo Company plc (2023 - 1992)

Historical Annual Eps of Perrigo Company plc (2023 - 1992)

Peer Eps Comparison of Perrigo Company plc